IDM Pharma

Irvine, United States Founded: 1990 • Age: 36 yrs Acquired By Takeda
Cancer immunotherapies were developed by this US-based biotech firm.
Request Access

About IDM Pharma

IDM Pharma is a company based in Irvine (United States) founded in 1990 was acquired by Takeda in May 2009.. IDM Pharma operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others.

  • Headquarter Irvine, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $12.5 M (USD), Post-IPO

    Feb 21, 2007

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Takeda

    (May 18, 2009)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of IDM Pharma

  • Total Funding
  • Total Rounds 1
  • Last Round Post-IPO — $12.5M
  • First Round

    (21 Feb 2007)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Feb, 2007 Amount Post-IPO - IDM Pharma Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in IDM Pharma

IDM Pharma has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Takeda Pharmaceuticals, Palo Alto Investors and Alta Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Healthcare sector investments are managed through private equity strategies.
Founded Year Domain Location
Venture capital firm focused on healthcare companies
Founded Year Domain Location
Takeda Pharmaceuticals is engaged in developing innovative medicines globally.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by IDM Pharma

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - IDM Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Idm Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of IDM Pharma

IDM Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Novel biopharmaceutical medicines are developed for unmet medical needs.
domain founded_year HQ Location
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
domain founded_year HQ Location
Small molecule therapeutics for cancer treatment are developed.
domain founded_year HQ Location
Cancer therapies are developed using selective pathway inhibitors.
domain founded_year HQ Location
MicroRNA-based therapeutics are developed for treating multiple diseases.
domain founded_year HQ Location
Therapeutics for cancer and rare diseases are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Idm Pharma

Frequently Asked Questions about IDM Pharma

When was IDM Pharma founded?

IDM Pharma was founded in 1990 and raised its 1st funding round 17 years after it was founded.

Where is IDM Pharma located?

IDM Pharma is headquartered in Irvine, United States. It is registered at Irvine, California, United States.

What does IDM Pharma do?

IDM Pharma was founded in 1990 and headquartered in Irvine, United States, within the biotechnology sector. Focus was placed on developing immunotherapies for cancer treatment. MEPACT (mifamurtide) was advanced for osteosarcoma and received approval in Europe prior to the 2007 acquisition by Takeda. Development of Bexidem for bladder cancer was subsequently halted. Operations centered on innovative therapeutic solutions in oncology.

Who are the top competitors of IDM Pharma?

IDM Pharma's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.

Who are IDM Pharma's investors?

IDM Pharma has 3 investors. Key investors include Takeda Pharmaceuticals, Palo Alto Investors, and Alta Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available